These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19457646)

  • 1. Sertindole causes distinct electrocardiographic T-wave morphology changes.
    Nielsen J; Graff C; Hardahl T; Andersen MP; Kristoffersen J; Struijk JJ; Toft E; Meyer JM
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):702-7. PubMed ID: 19457646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sertindole on QTD and TPTE.
    Nielsen J; Andersen MP; Graff C; Kanters JK; Hardahl T; Dybbro J; Struijk JJ; Meyer JM; Toft E
    Acta Psychiatr Scand; 2010 May; 121(5):385-8. PubMed ID: 20085555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia.
    Nielsen J; Matz J; Mittoux A; Polcwiartek C; Struijk JJ; Toft E; Kanters JK; Graff C
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):303-11. PubMed ID: 25583364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sertindole on QTc interval in patients with schizophrenia.
    Atmaca M; Yavuzkir M; Mermi O; Topuz M; Kanmaz E; Tezcan E
    Neurosci Lett; 2008 Sep; 442(1):1-3. PubMed ID: 18639380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of T-wave morphology increases confidence in drug-induced cardiac repolarization abnormalities: evidence from the investigational IKr inhibitor Lu 35-138.
    Graff C; Matz J; Christensen EB; Andersen MP; Kanters JK; Toft E; Pehrson S; Hardahl TB; Nielsen J; Struijk JJ
    J Clin Pharmacol; 2009 Nov; 49(11):1331-42. PubMed ID: 19843657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug safety and efficacy evaluation of sertindole for schizophrenia.
    Karamatskos E; Lambert M; Mulert C; Naber D
    Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need another atypical antipsychotic?
    Kasper S
    Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
    Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.
    Lindström E; Farde L; Eberhard J; Haverkamp W
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):615-29. PubMed ID: 15963244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertindole and impaired atrioventricular function, in the absence of Q-T prolongation: a case report.
    Rizos EN; Leftheriotis D; Douzenis A; Chatziioannou S; Siafakas N; Nika S; Kremastinos D; Lykouras L
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):442. PubMed ID: 20653911
    [No Abstract]   [Full Text] [Related]  

  • 11. The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe.
    Lançon C; Toumi M; Sapin C; Hansen K
    BMC Psychiatry; 2008 Jul; 8():57. PubMed ID: 18638382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
    Jukić MK; Drmić S; Mimica N
    Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
    Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
    Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
    Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.
    Wilton LV; Heeley EL; Pickering RM; Shakir SA
    J Psychopharmacol; 2001 Jun; 15(2):120-6. PubMed ID: 11448085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked elevation of creatine kinase with sertindole: a case report.
    Oulis P; Koulouris GC; Konstantakopoulos G; Masdrakis VG
    Pharmacopsychiatry; 2007 Nov; 40(6):295-6. PubMed ID: 18030658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Loss of consciousness during treatment with sertindole].
    Haberfellner EM
    Psychiatr Prax; 1999 May; 26(3):150. PubMed ID: 10412716
    [No Abstract]   [Full Text] [Related]  

  • 19. The Sertindole Cohort Prospective (SCoP) study: rationale, design and methodology.
    Peuskens J; Tanghøj P; Mittoux A;
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):425-33. PubMed ID: 18384186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertindole for the treatment of schizophrenia.
    Azorin JM; Kaladjian A; Fakra E; Adida M
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.